Clinical trial for Fabry disease faces continuing hurdles.
Silversides
Ann
A
D002170:Canada; D002986:Clinical Trials as Topic / Q000191:economics*; D000795:Fabry Disease / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D007527:Isoenzymes / Q000600:supply & distribution / Q000627:therapeutic use*; D000519:alpha-Galactosidase / Q000600:supply & distribution / Q000627:therapeutic use*
D007527:Isoenzymes; D000519:alpha-Galactosidase; C459420:agalsidase beta